Back to Results

Acme United Corporation (ACU)

Acme United Corporation is a common stock listing on the NYSE representing an operating company focused on cutting, measuring, first aid, and sharpening products. The company serves school, home, office, hardware, sporting goods, and industrial customers across the United States, Canada, Europe, and other international markets. Its brands include Westcott for scissors, rulers, sharpeners, paper trimmers, cutters, glue guns, and related craft items; Clauss for cutting tools; DMT for sharpening products; and First Aid Only, PhysiciansCare, Spill Magic, First Aid Central, Safety Made, Med-Nap, Pac-Kit, and My Medic for first aid, safety, and cleaning products. Acme United sells through independent representatives, wholesale and retail distribution channels, and its own websites. The company was founded in 1867, was formerly known as Acme Shear Company, and is based in Shelton, Connecticut.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-ACU
$52.82
-16.8% Downside
Fair
$58
-8.6% Downside
Fair
Great
1.0%
24.8x
2.0x
1.2x
243.4 M
276.8 M
13.7%
78.5%
5.0
24.4%
157.8%
Valuation • Fair Value

Acme United Corporation (NYSE-ACU) Fair Value by Valuation Model

Review the available estimates for Acme United Corporation (NYSE-ACU), including DCF Fair Value, Ben Graham Formula Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$52.82

Estimated downside of 16.8% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$48.24

Discounted cash flow valuation reference.

Ben Graham Formula Value

$28.40

Classic Ben Graham valuation formula reference.

EPV Fair Value

$54.71

Earnings power value estimate.

Comps Fair Value

$55.55

Comparable-company valuation reference.

Analyst Price Target

$58

Analysts imply downside of 8.6%.

How to read these valuation models

Use the 7 available valuation references for Acme United Corporation (NYSE-ACU) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Acme United Corporation (NYSE-ACU)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

211.6 M

Current operating scale indicator.

Revenue Forecast

226 M

Forward revenue estimate.

EBITDA

21.723 M

Current operating profitability reference.

EBITDA Forecast

24 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Acme United Corporation (NYSE-ACU) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Acme United Corporation (NYSE-ACU)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-2.74

No elevated caution signal from this screen.

Altman Z-Score

5.0

Relatively strong balance-sheet zone.

FCF / Net Income

157.8%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Acme United Corporation (NYSE-ACU). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Acme United Corporation (NYSE-ACU)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

1.0%

Current income yield reference.

Payout Ratio

24.4%

Dividend payout reference.

How to read events and dividends

Review the currently available dividend data for Acme United Corporation (NYSE-ACU). No upcoming company event date is included in the latest data.

Stock Forecast • Technical Outlook

Acme United Corporation (NYSE-ACU) Stock Forecast & Technical Outlook

Review Acme United Corporation (NYSE-ACU) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for Acme United Corporation (NYSE-ACU) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Acme United Corporation (NYSE-ACU) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Acme United Corporation (NYSE-ACU) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Acme United Corporation (NYSE-ACU) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Acme United Corporation (NYSE-ACU) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Acme United Corporation (NYSE-ACU)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Acme United Corporation (NYSE-ACU) has a Hold consensus, with 0 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 0
Hold 1
Sell 0
FAQ • Fast Investor Answers

Acme United Corporation (NYSE-ACU) Stock FAQ

Data-supported answers about Acme United Corporation (NYSE-ACU), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$52.82
Estimated downside 16.8%
Valuation Rating
Overvalued
Estimated downside of 16.8%
Analyst Target
$58
Implied downside 8.6%
Financial Health
Great
Current financial-health read

The current fair value estimate for Acme United Corporation (NYSE-ACU) is $52.82. This implies an estimated downside of 16.8% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 16.8% versus the current market price.

The available analyst price target for Acme United Corporation (NYSE-ACU) is $58. The analyst target implies estimated downside of 8.6%.

The current financial health read for Acme United Corporation (NYSE-ACU) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Based on the current data, dividend yield is 1.0%.

The current P/E ratio listed for Acme United Corporation (NYSE-ACU) is 24.8x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Acme United Corporation is 243.4 M.

The current enterprise value listed for Acme United Corporation is 276.8 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Acme United Corporation is NYSE-ACU, and the stock is listed on NYSE.

Acme United Corporation (NYSE-ACU) is listed on NYSE.

The current debt-to-total-capital ratio listed for Acme United Corporation is 13.7%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Acme United Corporation is 78.5%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Equipment & Supplies Stocks View more on NYSE

Comparable companies from the same industry, limited to one security per issuer.

ABT NYSE Abbott Laboratories Fair Value Fair Market Cap 179.4 B
ISRG NASDAQ Intuitive Surgical Inc Fair Value Fair Market Cap 156.8 B
SYK NYSE Stryker Corporation Fair Value Fair Market Cap 117.8 B
MDT NYSE Medtronic PLC Fair Value Fair Market Cap 116.8 B
BSX NYSE Boston Scientific Corp Fair Value Undervalued Market Cap 66.215 B
BDX NYSE Becton Dickinson and Co Fair Value Undervalued Market Cap 54.18 B
EW NYSE Edwards Lifesciences Corp Fair Value Fair Market Cap 51.34 B
MDLN NASDAQ Medline Inc Fair Value Fair Market Cap 44.818 B
IDXX NASDAQ IDEXX Laboratories Inc Fair Value Fair Market Cap 44.147 B
RMD NYSE ResMed Inc Fair Value Fair Market Cap 35.562 B
ALC NYSE Alcon AG Fair Value Undervalued Market Cap 33.943 B
GEHC NASDAQ GE HealthCare Technologies Inc Fair Value Undervalued Market Cap 32.273 B
DXCM NASDAQ DexCom Inc Fair Value Undervalued Market Cap 29.411 B
PHG NYSE Koninklijke Philips NV ADR Fair Value Fair Market Cap 26.348 B
STE NYSE STERIS plc Fair Value Fair Market Cap 22.635 B
ZBH NYSE Zimmer Biomet Holdings Inc Fair Value Fair Market Cap 18.799 B
SOLV NYSE Solventum Corp Fair Value Fair Market Cap 14.539 B
BAX NYSE Baxter International Inc Fair Value Fair Market Cap 13.08 B
SNN NYSE Smith & Nephew SNATS Inc Fair Value Undervalued Market Cap 12.906 B
PEN NYSE Penumbra Inc Fair Value Fair Market Cap 12.778 B